220 related articles for article (PubMed ID: 843424)
1. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
Ellard GA; Gammon PT
Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
[TBL] [Abstract][Full Text] [Related]
2. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
Ellard GA
Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):610-25. PubMed ID: 773583
[TBL] [Abstract][Full Text] [Related]
3. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
4. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
Mason E; Russell DW
Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
[TBL] [Abstract][Full Text] [Related]
6. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
7. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
[TBL] [Abstract][Full Text] [Related]
9. [The importance of estimating the individual acetylation rate in modern tuberculosis treatment].
Duru S
Mikrobiyol Bul; 1979 Jan; 13(1):53-61. PubMed ID: 555792
[TBL] [Abstract][Full Text] [Related]
10. Incidence of isoniazid acetylation phenotypes in North Indians.
Gupta RC; Nair CR; Jindal SK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
[TBL] [Abstract][Full Text] [Related]
11. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA
Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570
[TBL] [Abstract][Full Text] [Related]
12. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
[TBL] [Abstract][Full Text] [Related]
13. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
14. Determination of the acetylator phenotype using matrix isoniazid.
Ellard GA; Gammon PT; Titinen H
Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
[TBL] [Abstract][Full Text] [Related]
15. Influence of rifampicin and isoniazid on the kinetics of phenytoin.
Kay L; Kampmann JP; Svendsen TL; Vergman B; Hansen JE; Skovsted L; Kristensen M
Br J Clin Pharmacol; 1985 Oct; 20(4):323-6. PubMed ID: 4074601
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype.
Yamamoto T; Suou T; Hirayama C
Hepatology; 1986; 6(2):295-8. PubMed ID: 3957235
[TBL] [Abstract][Full Text] [Related]
17. The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.
Víznerová A; Slavíková Z; Ellard GA
Tubercle; 1973 Mar; 54(1):67-71. PubMed ID: 4774936
[No Abstract] [Full Text] [Related]
18. Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man.
Jenner PJ; Ellard GA
Tubercle; 1989 Jun; 70(2):93-101. PubMed ID: 2617692
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of isoniazid.
Weber WW; Hein DW
Clin Pharmacokinet; 1979; 4(6):401-22. PubMed ID: 391461
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
Hall S
Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
